|
||
|
Axxima Pharmaceuticals AG
Download PDF Members: Axxima™ Pharmaceuticals AG (formerly VirGene) is the leader in the application of pathogen-host signal transduction intervention. The company develops proprietary drugs that are based on Axxima's revolutionary approach to generate a Signal Transduction Firewall™ (STF™) against pathogens. Axxima's business strategy is to pursue the highly desirable area of anti-infective drug discovery from beginning to end, from target identification to drug development, making it a small pharmaceutical company rather than a traditional platform-based biotechnology startup. Axxima has developed a technology platform directed towards the identification of "critical" interaction points between a pathogen and target cells in the host. Axxima is developing small molecule drugs to interfere at these critical interaction points, thus blocking the pathogen's manipulation of the host cell and leaving the pathogen without the tools with which to establish itself in the host.
This page has been viewed 414 times since April 2007, the link to the organisation's website has been followed 82 times Recent Search Terms used to find this page: axxima | axxima pharmaceuticals tel | Axxima Pharmaceuticals AG | axxima pharmaceuticals tel | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals AG | Axxima Pharmaceuticals | t | . Search for more companies in Martinsried Search for more companies in Bavaria This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Axxima Pharmaceuticals AG | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nothing in this website should be used in place of personal medical
advice from your own qualified medical practitioner. See
User
Agreement |
All rights reserved. All other trademarks recognized. |
|
|